What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
University of North Carolina at Chapel Hill · The University of Texas Southwestern Medical Center · +4 more institutions
Abstract
The authors provide an overview of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study (www.star-d.org), a large-scale practical clinical trial to determine which of several treatments are the most effective "next-steps" for patients with major depressive disorder whose symptoms do not remit or who cannot tolerate an initial treatment and, if needed, ensuing treatments. Entry criteria were broadly defined and inclusive, and patients were enrolled from psychiatric and primary care clinics. All participants began on citalopram and were managed by clinic physicians, who followed an algorithm-guided acute-phase treatment through five visits over 12 weeks. At the end of each sequence, patients…
Citation impact
- FWCI
- 11.15
- Percentile
- 100%
- References
- 0
Authors
6Topics & keywords
- Depression (economics)
- Clinical trial
- Randomized controlled trial
- Medicine
- Psychiatry
- Major depressive disorder
- Citalopram
- Antidepressant